Treatment of latent TB Infection and the risk of tuberculosis after solid organ transplantation: Comprehensive review.

Cybele Lara R AbadPaul J DezielRaymund R Razonable

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2019)

Latent TB infection treatment is efficacious in SOT recipients at risk of TB disease. However, tuberculosis may still occur despite LTBI treatment. Hepatotoxicity associated with LTBI therapy is infrequent, although more commonly observed among liver recipients.

Keyphrases

mycobacterium tuberculosis
stem cells
emergency department
mesenchymal stem cells
hiv aids
bone marrow